Seeking Alpha

More on McKesson's FQ3: The company expects FY12 EPS of $6.19-$6.39, compared with a $6.33...

More on McKesson's FQ3: The company expects FY12 EPS of $6.19-$6.39, compared with a $6.33 consensus. It's also acquiring Drug Trading Company Ltd., the "marketing and purchasing arm" for a network of over 850 Canadian pharmacies, and Medicine Shoppe, a provider of services to over 160 Canadian pharmacies, from Katz Group. The deal will cost ~$918M in cash. MCK +3.3% AH. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs